Bank of America Corporation (BAC) vs Johnson & Johnson (JNJ)

Bank of America Corporation is one of the largest U.S. financial institutions, with a $3.5 trillion balance sheet and the second-largest deposit market share in the country, underscoring its central role in the American economy. The company has preserved a strong position among domestic middle-market and retail customers while also maintaining a significant international presence, supported by the world’s fourth-largest trading operation and an investment banking business that consistently ranks among the top four in global league tables. Bank of America operates through four main segments: consumer banking, global wealth and investment management, global banking, and global markets.

Johnson & Johnson is the world’s largest and most diversified healthcare company. Its operations are organized into two segments: Innovative Medicine and MedTech, which together account for all revenue following the 2023 separation of its consumer health business, Kenvue. After restructurings completed in 2023 and 2024, the pharmaceutical segment is focused on three core therapeutic areas: immunology, oncology, and neurology. From a geographic perspective, slightly more than half of the company’s total revenue comes from the United States.